Provided by Tiger Trade Technology Pte. Ltd.

Recursion Pharmaceuticals, Inc.

3.22
-0.2250-6.54%
Pre-market: 3.21-0.0050-0.16%07:08 EDT
Volume:14.20M
Turnover:46.48M
Market Cap:1.72B
PE:-3.15
High:3.45
Open:3.42
Low:3.21
Close:3.44
52wk High:7.18
52wk Low:2.77
Shares:535.00M
Float Shares:522.33M
Volume Ratio:0.87
T/O Rate:2.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0219
EPS(LYR):-1.4410
ROE:-56.58%
ROA:-27.33%
PB:1.88
PE(LYR):-2.23

Loading ...

Recursion Pharmaceuticals misses Q1 operating revenue estimates, net loss narrows

Reuters
·
May 06

Recursion Pharmaceuticals Q1 EPS $(0.22) Beats $(0.27) Estimate, Sales $6.472M Miss $15.777M Estimate

Benzinga Earnings
·
May 06

BRIEF-Recursion Pharmaceuticals Q1 Operating Revenue USD 6.301 Million Vs. IBES Estimate USD 15.8 Million

Reuters
·
May 06

Recursion Pharmaceuticals Q1 Operating Income USD -128.505 Million

THOMSON REUTERS
·
May 06

Recursion Reports First Quarter Financial Results and Provides Business Update

GlobeNewswire
·
May 06

Recursion Pharmaceuticals Inc expected to post a loss of 27 cents a share - Earnings Preview

Reuters
·
May 04

The Quest to Use AI to Help Find New Drugs -- WSJ

Dow Jones
·
May 02

Recursion Pharmaceuticals Is Maintained at Overweight by JP Morgan

Dow Jones
·
May 01

Recursion Pharmaceuticals Announces Planned Board Leadership Transition

TIPRANKS
·
May 01

Recursion founder Chris Gibson to step down from board in June

Reuters
·
May 01

Recursion Pharmaceuticals announces annual shareholder meeting

Reuters
·
May 01

Recursion Announces Board Transition

GlobeNewswire
·
May 01

Recursion Pharmaceuticals price target lowered to $10 from $11 at JPMorgan

TIPRANKS
·
Apr 30

Recursion updates financial calendar with upcoming first-quarter results and earnings call

Reuters
·
Apr 29

Press Release: Recursion to Report First Quarter 2026 Business Updates and Financial Results on May 6

Dow Jones
·
Apr 29

GPT-Rosalind Sparks CRO Sector Slump: Should Investors Buy the Dip or Exit Amid AI Drug R&D Impact?

TradingKey
·
Apr 17

Recursion Pharmaceuticals director Christopher Gibson disposes 40,000 shares for $124,000

Reuters
·
Apr 09

Recursion director Blake Borgeson disposes of 30,000 shares for $93,000

Reuters
·
Apr 09

Recursion to Present at Needham Virtual Healthcare Conference

Reuters
·
Apr 07

Recursion to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Apr 07